Aripiprazole is reported to be effective in child and adolescent patients with schizophrenia, bipolar disorder (BPD), attention deficit hyperactivity disorder (ADHD), pervasive developmental disorder (PDD), tic disorder (TD) and obsessive-compulsive disorder (OCD).